Start: August 20, 2021
End: January 31, 2023
Enrollment: 40
Transcranial direct current stimulation (tDCS) is a noninvasive therapy that delivers weak electrical current to stimulate the brain. This study will measure the effectiveness and feasibility of home-based tDCS to lessen apathy in people with Alzheimer's disease or a related dementia. Participants will be randomly assigned to receive either tDCS therapy or a sham treatment at home. Caregivers will set up and administer the treatment for up to six weeks and researchers will remotely monitor the at-home sessions. Each week and six weeks after the last treatment, the researchers will collect information about changes in cognition, apathy, and other behavioral and psychological symptoms of dementia. Researchers will also collect any side effects and participant experiences with the home treatment.
Minimum Age: 60 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Texas | |
---|---|
The University of Texas Health Science Center at Houston
Houston, TX 77030
Recruiting
Antonio L Teixeira Jr, MD,PhD,MSc |
Lead: The University of Texas Health Science Center, Houston
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT04855643